.png){kind=icon}
返回
Deep Learning-Assisted Compound Bioactivity Estimation Framework
.png){kind=icon}
OA
AI
DOI：10.1016/j.eij.2024.100558.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Drug Discovery is a highly complicated process. On average, it takes six to twelve years to manufacture a new drug and have the product released in the market. It is of utmost importance to find methods that would accelerate the manufacturing process. This significant challenge in drug development can be addressed using deep learning techniques. The aim of this paper is to propose a deep learning-based framework that can help chemists examine compound biological activity in amore accurate manner. The proposed framework employs autoencoder for data representation of the compounds data, which is then classified using deep neural network followed by building a customized deep regression model to estimate an accurate value of the compound bioactivity. The proposed framework achieved an accuracy of 89% in autoencoder reconstruction error, 79.01% in classification, and MAE of 2.4 while predicting compound bioactivity using deep regression model.
Keyword:
Drug discovery
Deep learning
Regression
Auto-encoder
Classification
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
4.3
论文数:
786
被引数:
1.4K
机构
引用论文
分享收藏Pathways and challenges of the application of artificial intelligence to geohazards modelling.png)
GONDWANA RESEARCHOAAI
GONDWANA RESEARCHIF8.6
OAAI分享收藏Improving the quality of chemical language model outcomes with atom-in-SMILES tokenization通过微笑中的原子标记化提高化学语言模型结果的质量OAAI
OAAI分享收藏
查看更多内容